PTGX

News Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer

14d ago

News Johnson & Johnson, Protagonist Study Shows Superior Skin Clearance In Psoriasis Trials

14d ago

Insider trade Sale by PATEL DINESH V PH D (President and CEO)

20d ago

Insider trade Sale by Bryan Giraudo

21d ago

Insider trade Sale by Bryan Giraudo

21d ago

Insider trade Sale by Asif Ali (Chief Financial Officer)

39d ago

Insider trade Sale by Asif Ali (Chief Financial Officer)

41d ago

Insider trade Sale by PATEL DINESH V PH D (President and CEO)

68d ago

News Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie

75d ago

News J&J wins FDA nod for plaque psoriasis pill developed with Protagonist

76d ago

Insider trade Sale by William D. Waddill

104d ago

Insider trade Sale by Asif Ali

104d ago

Insider trade Sale by Arturo Molina MD

104d ago

Insider trade Sale by PATEL DINESH V PH D

104d ago

Insider trade Sale by PATEL DINESH V PH D

104d ago

Insider trade Sale by Asif Ali

104d ago

Insider trade Sale by Arturo Molina MD

104d ago

News ClearBridge Small-Cap Growth trims Duolingo, Biohaven, QLYS; Adds PTGX, SSD, BETA, DYN in Q4

131d ago

News Johnson & Johnson In Talks To Acquire Protagonist Therapeutics: Report

153d ago

News Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today

153d ago

News Douglas Lane Adds $6 Million in J&J Stock Ahead of Earnings and Possible Biotech Deal

153d ago

News FDA Adds New Warning For Johnson & Johnson's Cancer Cell Therapy

153d ago

News Johnson & Johnson To Separate Orthopedics Business, Boosts Annual Sales Outlook

153d ago

News Moody Aldrich Dumps Entire Stake in Chart Industries Worth $5.8 Million

153d ago